Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Clever Bioscience S R L is managing 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed among 2 distinct examiners but are concentrated within 1 distinct art unit. COFFA, SERGIO is the busiest examiner, with 1 busiest examiner pending action. This indicates that each of the 2 pending office actions is being handled by a different examiner.
The use of 1 distinct art unit suggests that both applications relate to very similar technical subject matter within the biotechnology field. Although the company engages 2 distinct examiners, the lack of diversity in art units means prosecution is subject to the specific culture of a single technical group. COFFA, SERGIO manages 1 busiest examiner pending action, which is half of the total active workload. This structure allows the company to receive feedback from 2 distinct examiners on similar technical concepts. Practitioners should note that the concentration in 1 distinct art unit may lead to consistent examination standards across the 2 pending office actions.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| COFFA, SERGIO | 1 | 61.1% | +32.5% |
| KATAKAM, SUDHAKAR | 1 | 74.7% | +23.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18576928 | LIPOSOMES CONTAINING SYNERGISTIC ANTIMICROBIAL COMPOSITIONS BASED ON SELECTED PEPTIDES AND FATTY ACIDS | COFFA, SERGIO | — |
| 18576531 | Synergistic antimicrobial compositions containing selected peptides and fatty acids | KATAKAM, SUDHAKAR | — |
| Art Unit | Apps |
|---|---|
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18576928 | LIPOSOMES CONTAINING SYNERGISTIC ANTIMICROBIAL COMPOSITIONS BASED ON SELECTED PEPTIDES AND FATTY ACIDS | COFFA, SERGIO | — | §103 | Non-Final OA | — | Pending | Jan 05, 2024 |
| 18576531 | Synergistic antimicrobial compositions containing selected peptides and fatty acids | KATAKAM, SUDHAKAR | 1658 | §103 | Non-Final OA | — | Pending | Jan 04, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial